![(3S)-3-({5-amino-1-[(2-methoxy-4-{[(oxan-4-yl)amino]methyl}phenyl)methyl]-1H-pyrazolo[4,3-d]pyrimidin-7-yl}amino)hexan-1-ol in PDB entry 8ttz, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/8ttz_entity_5_side_image-200x200.png "Homo dimeric assembly 1 of PDB entry <span class='highlight'>8ttz</span> contains 2 copies of <span class='highlight'>(3S)-3-({5-amino-1-[(2-methoxy-4-{[(oxan-4-yl)amino]methyl}phenyl)methyl]-1H-pyrazolo[4,3-d]pyrimidin-7-yl}amino)hexan-1-ol</span>. Side view.")
![(3S)-3-({5-amino-1-[(2-methoxy-4-{[(oxan-4-yl)amino]methyl}phenyl)methyl]-1H-pyrazolo[4,3-d]pyrimidin-7-yl}amino)hexan-1-ol in PDB entry 8ttz, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/8ttz_entity_5_top_image-200x200.png "Homo dimeric assembly 1 of PDB entry <span class='highlight'>8ttz</span> contains 2 copies of <span class='highlight'>(3S)-3-({5-amino-1-[(2-methoxy-4-{[(oxan-4-yl)amino]methyl}phenyl)methyl]-1H-pyrazolo[4,3-d]pyrimidin-7-yl}amino)hexan-1-ol</span>. Top view.")
Environment details NEW
QCX 926 bound to chain A
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.